Sucralfate and Isoptin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Isoptin (verapamil hydrochloride). Common drug interactions include abscess limb among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Isoptin. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Isoptin?

Isoptin has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,539 Isoptin users. Check the latest studies of Isoptin.



On Jul, 14, 2026

11 people who take Sucralfate and Isoptin together, and have interactions are studied.

Sucralfate and Isoptin drug interactions.

What are the common drug interactions of Sucralfate and Isoptin, by gender? *:

female:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Perirectal abscess
  4. Subcutaneous abscess
  5. Anal abscess
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Genital abscess (build up of pus in genital)
  8. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  9. Multi-organ failure (multisystem organ failure)
  10. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Blood alkaline phosphatase nos increased
  5. Drug effect decreased
  6. Liver disorder (liver diseases)
  7. Blood alkaline phosphatase increased
  8. Multi-organ failure (multisystem organ failure)
  9. Acute respiratory distress syndrome
  10. Adult respiratory distress syndrome (type of lung (pulmonary) failure)

What are the common drug interactions of Sucralfate and Isoptin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abscess limb (limb infection)
  2. Cellulitis (infection under the skin)
  3. Perirectal abscess
  4. Subcutaneous abscess
  5. Anal abscess
  6. Genital abscess (build up of pus in genital)
  7. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  8. Panic attack

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  4. Blood alkaline phosphatase nos increased
  5. Drug effect decreased
  6. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  7. Liver disorder (liver diseases)
  8. Pulmonary thrombosis (scarring in the lungs)
  9. Stevens johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  10. Thrombosis (formation of a blood clot inside a blood vessel)

What are the existing conditions these people have? *

  1. Weight Decreased: 2 people, 18.18%
  2. Type 2 Diabetes: 2 people, 18.18%
  3. Hypotension (abnormally low blood pressure): 2 people, 18.18%
  4. Pneumonia: 1 person, 9.09%
  5. Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 9.09%
  6. Atypical Pneumonia (acute respiratory disease marked by high fever and coughing): 1 person, 9.09%
  7. Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Isoptin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sucralfate and Isoptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Isoptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sucralfate and verapamil hydrochloride (the active ingredients of Sucralfate and Isoptin, respectively), and Sucralfate and Isoptin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: